Maher Rabah, DO
Interventional Cardiology · Berkley, MINPI 1013967793
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (43.7%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 64.3% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2022 at $1,494 and has fallen 76.9% since, to $345 in 2025. That places this record below the midpoint for interventional cardiology clinicians in MI, where the typical reported total is $6,857.
Across 77 payments — averaging $45.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$2K
- Inari Medical, Inc.$870
- Abiomed$248
- Medtronic$116
- E.r. Squibb & Sons, L.L.C.$15
- Biotronik Inc.$13
What the payments were for
- Speaking & faculty fees$1,23635%
- Travel & lodging$75721%
- Food & beverage$1,54644%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 66 | $2,276 |
| Inari Medical, Inc. | 5 | $870 |
| Abiomed | 3 | $248 |
| Medtronic | 1 | $116 |
| E.r. Squibb & Sons, L.L.C. | 1 | $15 |
| Biotronik Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AngioJet XMI$1,236
- FLOWTRIEVER CATHETER, S$757
- CT THROMBECTOMY SYSTEM KIT$757
- SYNERGY$125
- ONYX FRONTIER$116
- Impella$107
- COMET$102
How this compares
$3,539 in reported general payments places this provider in the 35th percentile of 187 interventional cardiology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 575 | $643,710 |
| Repatha SureclickEvolocumab | 313 | $269,320 |
| EntrestoSacubitril/Valsartan | 233 | $262,955 |
| JardianceEmpagliflozin | 140 | $149,118 |
| XareltoRivaroxaban | 107 | $127,916 |
| Praluent PenAlirocumab | 75 | $66,784 |
| Rosuvastatin Calcium | 907 | $17,569 |
| Metoprolol Succinate | 918 | $15,427 |
| FarxigaDapagliflozin Propanediol | 11 | $14,128 |
| Ezetimibe | 618 | $11,503 |
| VascepaIcosapent Ethyl | 23 | $11,435 |
| ClopidogrelClopidogrel Bisulfate | 634 | $11,228 |
| Ranolazine ErRanolazine | 103 | $10,007 |
| Atorvastatin Calcium | 725 | $9,487 |
| BrilintaTicagrelor | 15 | $8,924 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Berkley
- Amr AbbasBerkley$416K
- Amir KakiDetroit$1.8M
- Tamam MohamadDetroit$960K
- Paul GrossmanAnn Arbor$630K
- Jason RicciPetoskey$594K
- Tim FischellKalamazoo$468K
- Mir BasirDetroit$442K
- Safwan KassasSaginaw$340K
- Vishal GuptaKalamazoo$293K
- Khaldoon AlaswadDetroit$276K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.